Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in PLUR — Pluri Inc.

CIK 72971 SAN FRANCISCO, CA
Back to PLUR Full portfolio

Position in PLUR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$386
-$243 QoQ
Shares Held
185
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 16 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PLUR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. PLUR ranks #377 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in PLUR

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $386 185
2026-03-31 $629 185
2025-12-31 $552 185
2025-09-30 $828 185
2025-06-30 $915 185
2025-03-31 $795 185
2024-12-31 $749 175
2024-09-30 $1,058 175
2024-06-30 $1,011 175
2024-03-31 $1,134 1,401
2023-12-31 $812 1,401
2023-09-30 $1,560 2,601
2023-06-30 $1,920 2,400
2023-03-31 $2,040 2,000
2022-12-31 $940 1,000
2022-09-30 $780 1,000